British private insurer AXA Health has said it will not pay for treatment with Novo Nordisk’s weight-loss drug Wegovy, which launched in the U.K. on Monday. AXA Health told Reuters in a statement: “As it stands, AXA Health would not cover the use of Wegovy as this would be…[#item_full_content]
Il lavoro che non paga tra stipendi da fame e contratti precari: centomila giovani via dall’Italia
Read More [#item_full_content]